The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.
Who Should Attend?
This course is designed for providers in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.
Review Learning Objectives with Course Directors
At course completion, attendees should be able to:
· Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, hepatocellular carcinoma, and viral hepatitis.
· Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.
· Foster the development of multidisciplinary and interactive models to treat liver diseases.
· Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.
Register for free by March 1, 2022
Continuing Education Credit
Allegheny General Hospital designates this
live activity for a maximum of 2.75 AMA PRA
Category 1 Credits TM. Physicians should claim
only the credit commensurate with the extent
of their participation in the activity.
Disclosure of Significant Relationships with Relevant
In accordance with the Accreditation Council for
Continuing Medical Education (ACCME) and the
policy of Allegheny General Hospital, presenters
must disclose all relevant financial relationships,
which in the context of their presentation(s), could
be perceived as a real or apparent conflict of
interest, (e.g., ownership of stock, honorarium, or
consulting fees). Any identifiable conflicts will be
resolved prior to the activity. Any such relationships
will be disclosed to the learner prior to the
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Allegheny General Hospital and Community Liver Alliance.
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum of 2.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CLA PCP HCV Treatment Training Patient Treatment Data Log
Register below using the Cvent supported URL.